financetom
Business
financetom
/
Business
/
Hub Group Q2 Adjusted Earnings, Revenue Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hub Group Q2 Adjusted Earnings, Revenue Fall
Aug 1, 2025 1:13 AM

03:48 AM EDT, 08/01/2025 (MT Newswires) -- Hub Group ( HUBG ) reported Q2 adjusted earnings late Thursday of $0.45 per diluted share, down from $0.47 a year earlier.

Analysts polled by FactSet expected $0.44.

Revenue for the quarter ended June 30 was $905.6 million, compared with $986.5 million a year earlier.

Analysts surveyed by FactSet expected $918.8 million.

The company narrowed its 2025 earnings guidance to between $1.80 and $2.05 per share from $1.75 to $2.25 previously. It revised its annual revenue outlook to about $3.6 billion to $3.8 billion from $3.6 billion to $4 billion previously. Analysts surveyed by FactSet expect earnings of $1.92 per share on revenue of $3.78 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ARC Resources First-Quarter Profit Drops 68% on Lower Oil and Gas Prices
ARC Resources First-Quarter Profit Drops 68% on Lower Oil and Gas Prices
May 9, 2024
05:25 PM EDT, 05/09/2024 (MT Newswires) -- ARC Resources ( AETUF ) Thursday said its first-quarter profit fell 68% on lower natural-gas prices. The Western Canadian oil and gas producer said it earned C$185.4 million, or C$0.31 per share, down from C$574.9 million, or C$0.93, in the year-prior quarter. Revenue was not disclosed . The company said its first quarter...
Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
May 9, 2024
Recursion Pharmaceuticals Inc ( RXRX ) shares are rising in Thursday’s after-hours session following the company’s first-quarter financial results. Q1 Earnings: Recursion reported first-quarter revenue of $13.491 million, which beat analyst estimates of $12.65 million, according to Benzinga Pro. The company reported a quarterly loss of 39 cents per share, which beat estimates for a loss of 42 cents per...
Sun Life Financial Q1 Underlying Earnings Fall
Sun Life Financial Q1 Underlying Earnings Fall
May 9, 2024
05:21 PM EDT, 05/09/2024 (MT Newswires) -- Sun Life Financial ( SLF ) reported Q1 underlying earnings late Thursday of CA$1.50 a share ($1.10), down from CA$1.52 a year earlier. Analysts surveyed by Capital IQ expected CA$1.65. The company's board raised the quarterly dividend CA$0.03 to CA$0.81 a share, payable June 28 to shareholders of record May 29. ...
Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing
Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing
May 9, 2024
05:22 PM EDT, 05/09/2024 (MT Newswires) -- Pascal Deschatelets, Chief Scientific Officer, on May 08, 2024, sold 78,907 shares in Apellis Pharmaceuticals ( APLS ) for $3,341,848. Following the Form 4 filing with the SEC, Deschatelets has control over a total of 1,115,983 shares of the company, with 1,115,983 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1492422/000112760224014811/xslF345X03/form4.xml Price: 42.66, Change: +0.14, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved